UTSW awarded Dr. Joseph J. Pancrazio $1,971,800 for his research on Brain Glucose Deficiency: Mechanisms and Modulation.
Bioengineering Posts
Dr. Seth Hays Receives Over $2,300,000 from CDMRP
![](https://research.utdallas.edu/app/uploads/2024/02/Dr-Seth-Hays-resized-2.png)
Dr. Seth Hays received $2,317,051 from The Department of Defense’s Congressionally Directed Medical Research Programs for his research on Targeted Plasticity Therapy for the Treatment of Post-traumatic Stress Disorder.
Dr. Yichen Ding Obtains Nearly $2,000,000 From NIH
![Dr. Yichen Ding](https://research.utdallas.edu/app/uploads/2021/03/utdallas_54820770-2.jpg)
The National Institutes of Health (NIH) awarded Dr. Yichen Ding $1,883,456 for his research on Volumetric Imaging and Computation to Characterize Cardiac Electromechanical Coupling. This project focuses on establishing a new holistic strategy to in vivo investigate sophisticated electromechanical interaction, providing an entry point to further study the underlying mechanism of arrhythmias and prospectively identify arrhythmogenic compounds. Dr. Yichen …read more
Dr. Seth Hays’ Research on Service-Related Nerve Damage Is Funded By DoD
![Dr. Seth Hays](https://research.utdallas.edu/app/uploads/2021/02/Dr_Hays-1540-2.jpg)
The Department of Defense – Congressionally Directed Medical Research awarded Dr. Seth Hays $1,499,730 for his Restoring Sensory Function after Upper Limb Nerve Injury with Vagus Nerve Stimulation project. Dr. Hays’ research continues his work toward developing a novel therapy to treat loss of strength and touch sensation after damage to the nerves in the …read more
NIH Funds Dr. Girgis Obaid’s Molecular Cancer Project
![Dr. Girgis Obaid](https://research.utdallas.edu/app/uploads/2020/11/obaid-girgis-400.jpg)
The National Institutes of Health (NIH) awarded Dr. Girgis Obaid $723,942 for his research on Molecular Imaging-directed Bioengineering of Nanoconjugates as Adaptable Tumor Targeting Platforms. The project will utilize quantitative dual-tracer molecular binding imaging as the primary criterion for defining in vivo molecular selectivity of modular nanoconjugates at the cellular level, and will thus accurately …read more